
FREE
for Members
Epigenetics of Alzheimer's Disease
Wednesday, September 28, 2011
The burgeoning increase in the aging population is leading to an increase in the number of patients with common disorders of older adults such as Alzheimer's disease. Although some polymorphisms and risk factors have been associated with both sporadic and familiar forms of Alzheimer's disease, the precise manner by which the environment influences neurodegeneration in these disorders is still unclear. The purpose of this symposium is to discuss the most updated knowledge on the contribution of epigenetic modifications in the initiation and progress of Alzheimer's disease with the goal of advancing basic knowledge and identifying new areas for therapeutic interventions.
Registration Pricing
Member: | $0 |
Student / Postdoc / Fellow Member: | $0 |
Nonmember: | $30 |
Student / Postdoc / Fellow Nonmember: | $15 |
Agenda
1:00 PM | Opening Remarks |
1:15 PM | Enhancing Histone Acetyl Transferase Activity as a Therapeutic for Alzheimer’s Disease |
1:45 PM | Epigenetic Mechanisms Regulating Memory Formation in Health and Disease |
2:15 PM | Epigenetic Mechanisms in Memory Formation |
2:45 PM | Coffee Break |
3:15 PM | DNA Methylation and Alzheimer's Disease in Humans |
3:45 PM | Epigenetics of Alzheimer's Disease |
4:15 PM | Panel Discussion |
A 1-hour networking reception will follow the symposium.
Speakers
Organizers
Ottavio Arancio, MD, PhD
Columbia University Medical School
Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at SUNY HSCB. In 2004 he became Faculty member of the Dept of Pathology & Cell biology and The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at Columbia University. His honors include the “G. Moruzzi Fellowship” (Georgetown University), the “Anna Villa Rusconi Foundation Prize” (Italy), the “INSERM Poste vert Fellowship” (France), the AHAF centennial Award (2007), the Zenith Award (2007), the Margaret Cahn Research Award (2008), and the Edward N. and Della L. Thome Memorial Foundation Award (2010).
Dr Arancio is a cellular neurobiologist who has contributed to the characterization of the mechanisms of learning in both normal conditions and during neurodegenerative diseases. During the last ten years he has pioneered the field of mechanisms of synaptic dysfunction in Alzheimer’s disease. Dr. Arancio’s laboratory has focused primarily on events triggered by amyloid protein. These studies, which have suggested new links between synaptic dysfunction and amyloid protein, are of a general relevance to the field of Alzheimer’s disease both for understanding the etiopathogenesis of the disease and for developing therapies aiming to improve the cognitive symptoms.
Dr. Arancio has been recently featured on "bigthink.com".
Cecilia Marta, PhD
Sanofi-Aventis
Cecilia Marta obtained her PhD in Neuroscience from the University of Buenos Aires Argentina in 2000 working on the neuroimmune interactions of neurodegenerative disorders. She then continue her work as a postdoctoral fellow and then Assistant Professor at the University of Connecticut Health Center focusing on the neurodegenerative aspects of Multiple Sclerosis. In late 2005, she joined the CNS Department of Sanofi-Aventis to conduct drug discovery in the area of Multiple Sclerosis. In the beginning of 2010, she joined the newly formed Therapeutic Strategic Unit of Aging within Sanofi in which today she is part of the Translational Medicine team. Neurodegenerative disorders such as Alzheimer's and Parkinson's are part of the current strategic focus of the Unit.
Sonya Dougal, PhD
New York Academy of Sciences
Speakers
Paul D. Coleman, PhD
Sun Health Research Center
Paul Coleman received his undergraduate degree from Tufts (magna cum laude) and his Ph.D. from the University of Rochester. After a tour at the Army Medical Research Laboratory and a faculty position at Tufts he had a Special Fellowship at Johns Hopkins, working with Vernon Mountcastle and David Bodian. He then spent five years on the faculty at the University of Maryland School of Medicine, followed by more than 30 years as Professor in Neurobiology and Anatomy at the University of Rochester. During this time he spent portions of two summers at Cold Spring Harbor Laboratories, receiving training in molecular neurobiology, the latter summer with Jim Eberwine. He is now Professor Emeritus at the University of Rochester, Senior Scientist and Co-Director of Alzheimer Research at Banner Sun Health Research Institute. He is also Editor-in-Chief of “Neurobiology of Aging”.
J. David Sweatt, PhD
University of Alabama at Birmingham
J. David Sweatt obtained his B.S. in Chemistry from the University of South Alabama before attending Vanderbilt University, where he was awarded a Ph.D. for studies of intracellular signaling mechanisms. He then did a post-doctoral Fellowship at the Columbia University Center for Neurobiology and Behavior, working on memory mechanisms in the laboratory of Nobel laureate Eric Kandel. From 1989 to 2006 he was a member of the Neuroscience faculty at Baylor College of Medicine in Houston, Texas, rising through the ranks there to Professor and Director of the Neuroscience Ph.D. program.
Dr. Sweatt’s laboratory studies biochemical mechanisms of learning and memory. In addition, his research program also investigates mechanisms of learning and memory disorders, such as mental retardation and aging-related memory dysfunction. He is currently the Evelyn F. McKnight endowed Chairman of the Department of Neurobiology at UAB Medical School, and the Director of the Evelyn F. McKnight Brain Institute at the University of Alabama in Birmingham. He also is a Professor the Departments of Molecular Physiology and Biophysics, Genetics, and Psychology at UAB.
From 1998 until 2002 he attended drawing and painting classes at the Glassell School of Art of the Museum of Fine Arts, Houston. As an artist he explores the use of painting as a medium for expressing topics of interest in contemporary biomedical research. In 2009 he published a textbook, Mechanisms of Memory, which is illustrated with original paintings and describes current models for the molecular and cellular basis of memory formation.
Li-Huei Tsai, PhD
Massachusetts Institute of Technology
Li-‐Huei Tsai is the director of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology and a Picower Professor of Neuroscience. She is also a Principal Investigator in the Howard Hughes Medical Institute and the director of the Neurobiology Program at the Stanley Center for Psychiatric Research at the Broad Institute. Dr. Tsai received a PhD in microbiology at the University of Texas Southwestern Medical Center. She completed postdoctoral fellowships at Cold Spring Harbor Laboratory and the Massachusetts General Hospital. She became an Assistant Professor in the Department of Pathology at Harvard Medical School and, in 1997, she became an Investigator of the Howard Hughes Medical Institute. In 2006, Dr. Tsai became a Picower Professor of Neuroscience at the Massachusetts Institute of Technology (MIT) and became the Director of the Picower Institute for Learning and Memory in 2009. Dr. Tsai’s work has aimed to elucidate the cellular and molecular mechanisms that contribute to the development and manifestation of the pathology and symptoms of Alzheimer’s disease. Recently, Dr. Tsai’s laboratory has revealed that alternations of the epigenetic landscape can benefit cognition in Alzheimer’s disease animal models, even after severe neurodegeneration has occurred. These findings promise chromatin modifying enzymes to be potential targets for treatment of Alzheimer’s disease.
Benjamin Tycko, MD, PhD
Columbia University
Dr. Tycko is a Professor of Pathology and member of the Institute for Cancer Genetics at Columbia University. His work over the past two decades has centered on the role of DNA methylation in human development and disease. This work started with identification of human imprinted genes and their roles in Wilms tumor and Beckwith-Wiedemann syndrome and has continued with recent discoveries of altered epigenetic patterns in cancer-associated stromal cells. The most recent work from the Tycko lab has dealt with the epigenetics of Down syndrome and Alzheimer’s disease. Recent publications on human genetics and epigenetics from Dr. Tycko’s laboratory have appeared in basic and clinical journals including Nature Genetics, PLOS Genetics, Cancer Research and JAMA, and he is an author of the chapter on Epigenetics in the fifth and current edition of Emery and Rimoin’s Principles and Practice of Medical Genetics.
Yitshak Francis, PhD
Columbia University Medical Center
Yitshak Francis (PhD) is an Associate Research Scientist at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University. Dr. Francis completed his undergraduate degree at the Technion - Israel Institute of Technology where he graduated with honors. He obtained his PhD in Medical Molecular Biology from University College London, researching the role of epigenetics in Alzheimer’s disease under the direction of Professor David Latchman, renowned for his work in the field of transcription factors. During his work at Columbia University, Dr. Francis focused primarily on epigenetic changes triggered in Alzheimer’s disease. His research has led to the identification of novel epigenetics-modifying drugs. For his work Dr. Francis recently won the New Investigator research grant from the Alzheimer Association
Sponsors
For sponsorship opportunities please contact Carmen McCaffery at cmccaffery@nyas.org or 212.298.8642.
The Brain Dysfunction Discussion Group is proudly supported by:
Academy Friend
Promotional Partner
Abstracts
Enhancing Histone Acetyl Transferase Activity as a Therapeutic for Alzheimer's Disease
Yitshak Francis, PhD, Columbia University Medical Center
Epigenetic Mechanisms Regulating Memory Formation in Health and Disease
Li-Huei Tsai, PhD, Massachusetts Institute of Technology
Epigenetic Mechanisms in Memory Formation
J. David Sweatt, PhD, Department of Neurobiology, UAB School of Medicine
DNA Methylation and Alzheimer's Disease in Humans
Paul D. Coleman, PhD, Sun Health Research Center
Epigenetics of Alzheimer's Disease
Benjamin Tycko, MD, PhD, Columbia University
Travel & Lodging
Our Location
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157
212.298.8600
Hotels Near 7 World Trade Center
Recommended partner hotel
Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: 212.577.1133
The New York Academy of Sciences is a member of the Club Quarters network, which offers significant savings on hotel reservations to member organizations. Located opposite Memorial Plaza on the south side of the World Trade Center, Club Quarters, World Trade Center is just a short walk to the Academy.
Use Club Quarters Reservation Password NYAS to reserve your discounted accommodations online.
Other nearby hotels
212.693.2001 | |
212.385.4900 | |
212.269.6400 | |
212.742.0003 | |
212.232.7700 | |
212.747.1500 | |
212.344.0800 |